The largest database of trusted experimental protocols

Mission lentiviral shrnatransduction particles

Manufactured by Merck Group
Sourced in United States

The MISSION lentiviral shRNA transduction particles are a tool for delivering short hairpin RNA (shRNA) into target cells using a lentiviral vector system. The particles are designed to efficiently transduce a wide range of cell types and facilitate stable gene knockdown through the expression of the shRNA.

Automatically generated - may contain errors

3 protocols using mission lentiviral shrnatransduction particles

1

Lentiviral Transduction and Eosinophil Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34+ cells were transduced with MISSION lentiviral shRNA
transduction particles (Sigma- Aldrich, St. Louis, MO) at an MOI of 5 for 20
hours. Cells were collected, the viruses washed away, and the media supplemented
with 100 nM IL-3 and IL-5 (R&D Systems, Minneapolis, MN) for the remainder
of the experiment to promote differentiation of the eosinophil lineage. Cells
were maintained at a concentration of 0.3–1.0 × 106cell/mL for 14 or 21 days. Six days after the virus particles were removed, 2
μg/mL Puromycin (Sigma- Aldrich, St. Louis, MO) was added to the media in
order to select for cells transduced with the shRNA lentiviral particles. Cells
were stained using Fast Green/ Neutral Red and May-Grünwald Giemsa
(Sigma- Aldrich, St. Louis, MO) according to the manufacturer’s protocol.
Cell morphology on cytocentrifuge slides (Shandon Cytospin II, Thermo Fisher
Scientific, Waltham, MA) was evaluated by differential counts on sequential 40X
high power fields, counting at least 200 cells/slide.
+ Open protocol
+ Expand
2

RASSF1C Knockdown Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RASSF1C was silenced using Mission Non-Target shRNA Control Transduction Particles or with multiple Mission Lentiviral sh-RNA Transduction Particles (NMID: NM_007182, Sigma, St. Louis, MO, USA) as previously described [8 (link)].
+ Open protocol
+ Expand
3

RASSF1C Silencing in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung cancer cells (NCI-H1299) were plated at 5000/well in 96–well plates 24 hr. before infection and cells were infected with Mission Non-Target shRNA Control Transduction Particles or with multiple Mission Lentiviral shRNA Transduction Particles (NMID: NM_004764) for silencing RASSF1C (Sigma, St. Louis, MO) as previously described [14] (link). Cells were treated with polybrene (Sigma, ST. Louis, MO) for two hours before adding Lentiviral particle at a Multiplicity of Infection (MOI) of 5. Knockdown validation of piwil1 expression was assessed by Western blot and qRT-PCR using RASSF1C antibody and RASSF1C specific primers, respectively. The experiments were repeated at least 3 times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!